3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Hemorrhage
2
Hematologic Neoplasms
2
Thrombocytopenia
1
Postoperative Hemorrhage
1
Pelvic Mass
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Colonic Neoplasms
1
Breast Neoplasms
1
Breast Cancer Females
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
31
fludarabine
28
Whole-Body Irradiation
18
Mycophenolic Acid
18
venetoclax
14
Tacrolimus
14
fludarabine phosphate
13
Standard of Care
13
Specimen Handling
10
Practice Guidelines as Topic
10
Melphalan
10
Busulfan
10
Sirolimus
9
Thiotepa
8
Interviews as Topic
8
Azacitidine
8
Educational Status
7
trametinib
6
Surveys and Questionnaires
6
Methods
6
Mesna
6
Biopsy
6
thymoglobulin
5
Rituximab
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Early Intervention, Educational
5
Behavior Therapy
5
Antilymphocyte Serum
5
Peripheral Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Tranexamic Acid
×
1 year
×
Clear all
NCT04448184
2026-01-08
PATH
Ottawa Hospital Research Institute
Phase 3
Recruiting
662 enrolled
NCT03136445
2025-10-28
TREATT
NHS Blood and Transplant
Phase 3
Completed
616 enrolled
34 charts